ES2159921T3 - Imidazolinas sustituidas por un nucleo heterociclico, como 2-alfa-antagonistas. - Google Patents

Imidazolinas sustituidas por un nucleo heterociclico, como 2-alfa-antagonistas.

Info

Publication number
ES2159921T3
ES2159921T3 ES98401919T ES98401919T ES2159921T3 ES 2159921 T3 ES2159921 T3 ES 2159921T3 ES 98401919 T ES98401919 T ES 98401919T ES 98401919 T ES98401919 T ES 98401919T ES 2159921 T3 ES2159921 T3 ES 2159921T3
Authority
ES
Spain
Prior art keywords
imidazolins
heterociclical
alfa
antagonists
nucleus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98401919T
Other languages
English (en)
Inventor
Gerald Guillaumet
Jean-Yves Merour
Frederique Touzeau
Bruno Pfeiffer
Pierre Renard
Elisabeth Scalbert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADIR SARL
Original Assignee
ADIR SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADIR SARL filed Critical ADIR SARL
Application granted granted Critical
Publication of ES2159921T3 publication Critical patent/ES2159921T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

COMPUESTO DE FORMULA (I): EN LA QUE: - N ES IGUAL A 0 O 1, . Y REPRESENTA UN ATOMO DE OXIGENO, DE AZUFRE O UN GRUPO CH SUB,2 , POSEEN UNA GRAN AFINIDAD PARA LOS RECEPTORES EN LAS IMIDAZOLINAS.
ES98401919T 1997-07-30 1998-07-28 Imidazolinas sustituidas por un nucleo heterociclico, como 2-alfa-antagonistas. Expired - Lifetime ES2159921T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9709709A FR2766824B1 (fr) 1997-07-30 1997-07-30 Nouveaux composes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
ES2159921T3 true ES2159921T3 (es) 2001-10-16

Family

ID=9509815

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98401919T Expired - Lifetime ES2159921T3 (es) 1997-07-30 1998-07-28 Imidazolinas sustituidas por un nucleo heterociclico, como 2-alfa-antagonistas.

Country Status (20)

Country Link
US (1) US6057317A (es)
EP (1) EP0894796B1 (es)
JP (1) JPH1192476A (es)
CN (1) CN1090631C (es)
AT (1) ATE201871T1 (es)
AU (1) AU736460B2 (es)
BR (1) BR9802803A (es)
CA (1) CA2244435A1 (es)
DE (1) DE69800883T2 (es)
DK (1) DK0894796T3 (es)
ES (1) ES2159921T3 (es)
FR (1) FR2766824B1 (es)
GR (1) GR3036474T3 (es)
HK (1) HK1017685A1 (es)
HU (1) HUP9801713A1 (es)
NO (1) NO311256B1 (es)
NZ (1) NZ331154A (es)
PL (1) PL327747A1 (es)
PT (1) PT894796E (es)
ZA (1) ZA986815B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2799757B1 (fr) * 1999-10-15 2001-12-14 Adir Nouveaux derives polycycliques azaindoliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
BRPI0413968A (pt) 2003-09-01 2006-10-31 Ono Pharmaceutical Co composto de anel condensado e seu uso
CN1845911B (zh) * 2003-09-01 2012-07-04 小野药品工业株式会社 稠环化合物及其应用
US20070197512A1 (en) * 2006-01-27 2007-08-23 Japan Tobacco Inc. Carboxylic Acid Compounds and Use Thereof
EP1985297A1 (en) * 2006-01-27 2008-10-29 Japan Tobacco, Inc. Carboxylic acid compound and use thereof
TWI469965B (zh) * 2008-12-22 2015-01-21 Ono Pharmaceutical Co 乙炔基吲哚化合物
WO2011162222A1 (ja) 2010-06-21 2011-12-29 小野薬品工業株式会社 ４，４'－［４－フルオロ－７－（｛４－［４－（３－フルオロ－２－メチルフェニル）ブトキシ］フェニル｝エチニル）－２－メチル－１ｈ－インドール－１，３－ジイル］ジブタン酸、４，４'－［２－メチル－７－（｛４－［４－（ペンタフルオロフェニル）ブトキシ］フェニル｝エチニル）－１ｈ－インドール－１，３－ジイル］ジブタン酸および４，４'－［４－フルオロ－２－メチル－７－（｛４－［４－（２，３，４，６－テトラフルオロフェニル）ブトキシ］フェニル｝エチニル）－１ｈ－インドール－１，３－ジイル］ジブタン酸の新規結晶形
US9216998B2 (en) * 2012-02-15 2015-12-22 Janssen Pharmaceutica Nv Tricyclic indole derivatives useful endothelial lipase inhibitors
RU2687979C1 (ru) * 2018-03-19 2019-05-17 Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Способ коррекции стрептозотоцин-индуцированного сахарного диабета у крыс с использованием лекарственного средства на основе амида гетероциклических кислот

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ199469A (en) * 1981-01-30 1984-03-16 Reckitt & Colmann Prod Ltd Benzodioxanyl-2-imidazoline derivatives and pharmaceutical compositions
US4436914A (en) * 1981-08-03 1984-03-13 Kluge Arthur F Benzodioxane-imidazoline compounds as antihypertensives
NZ203680A (en) * 1982-04-17 1985-08-16 Reckitt & Colmann Prod Ltd Imidazolines and pharmaceutical compositions

Also Published As

Publication number Publication date
FR2766824A1 (fr) 1999-02-05
NO983478L (no) 1999-02-01
PT894796E (pt) 2001-09-28
HU9801713D0 (en) 1998-09-28
DK0894796T3 (da) 2001-09-03
EP0894796A1 (fr) 1999-02-03
CN1090631C (zh) 2002-09-11
GR3036474T3 (en) 2001-11-30
NO311256B1 (no) 2001-11-05
DE69800883T2 (de) 2002-03-28
FR2766824B1 (fr) 1999-09-10
US6057317A (en) 2000-05-02
HK1017685A1 (en) 1999-11-26
ATE201871T1 (de) 2001-06-15
AU736460B2 (en) 2001-07-26
NO983478D0 (no) 1998-07-28
PL327747A1 (en) 1999-02-01
NZ331154A (en) 1999-05-28
HUP9801713A1 (hu) 1999-12-28
BR9802803A (pt) 2000-03-21
ZA986815B (en) 1999-02-02
CN1206712A (zh) 1999-02-03
DE69800883D1 (de) 2001-07-12
EP0894796B1 (fr) 2001-06-06
JPH1192476A (ja) 1999-04-06
CA2244435A1 (fr) 1999-01-30
AU7860998A (en) 1999-02-11

Similar Documents

Publication Publication Date Title
AR006390A1 (es) Derivados de lactama
ES2059317T3 (es) Tolunitrilos alfa-heterociclo-sustituidos.
EA199900581A1 (ru) Производные индана или дигидроиндола
ES2155995T3 (es) Compuestos de 4-fenilpiperidina.
ES2168953A1 (es) Derivados de oxima y su uso como acidos latentes
DE3162445D1 (de) 3-aryloxy-3-phenylpropylamines
CO4700457A1 (es) DERIVADOS DE 4,9 ETANO-BENZO (f) ISOINDOL COMO INHIBIDORES DE FARNESIL TRANSFERASA
GT199900119A (es) Jarabe antihistaminico estabilizado.
YU46738B (sh) Postupak za dobijanje benzodiazepina
FI834872A0 (fi) Substituerade 4-aminoetylen-kromaner och -kromener, foerfaranden foer deras framstaellning och deraanvaendning som laekemedel
DE69918465D1 (de) Sulfonamidhydroxamate
ES2159921T3 (es) Imidazolinas sustituidas por un nucleo heterociclico, como 2-alfa-antagonistas.
CO4410319A1 (es) Derivados de fenetanolamina
MX9304399A (es) Proceso novedoso para preparar [[2-bromoetil)-amino]metil]-2-nitro-1h-imidazol-1-etanol quiral y compuestos relacionados.
EA200000910A1 (ru) Азабициклические лиганды рецепторов 5нт1
FI955498A0 (fi) Nipekotiinihappojohdannaisia hyytymistä estävinä aineina
EA200100517A1 (ru) Антагонисты 5ht1 для антидепрессантной терапии
ES2106936T3 (es) Derivados de carbazolona y procedimientos para su preparacion.
ES2055026T3 (es) Derivados de cicloalcanoles sustituidos con azol, un procedimiento para producirlos y un uso de los derivados como un fungicida agricola y horticola.
EA199901098A1 (ru) Новый способ
SE8401999L (sv) Aminodisulfider
ITMI931012A1 (it) Composti spiro-piranici dotati di caratteristiche fotocromatiche
EA200200727A1 (ru) Новые производные индола
SE8103580L (sv) N?726-substituerade adenosiner
FI822099A0 (fi) Maettade aminocyklitderivat, deras framstaellning och dessa innehaollande laekemedel

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 894796

Country of ref document: ES